PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Experimental Medicine, University of Tor Vergata, 00133 Rome, Italy.\', \'Department of Laboratory Medicine, Tor Vergata University Hospital, 00133 Rome, Italy.\', \'Immunology and Allergology Laboratory Unit, S. Giovanni di Dio Hospital, 50143 Florence, Italy.\', \'Department of Experimental and Clinical Medicine, University of Florence, 50121 Florence, Italy.\', \'Rheumatology Unit, S. Giovanni di Dio Hospital, 50143 Florence, Italy.\', \'Clinical Pathology Laboratory Unit, S. Giovanni di Dio Hospital, 50143 Florence, Italy.\', \'Department of Health Science, University of Florence, 50121 Florence, Italy.\', \'Laboratory of Virology, National Institute for Infectious Diseases Lazzaro Spallanzani, IRCCS, 00149 Rome, Italy.\', \'Emerging Technologies Division, International Federation Clinical Chemistry and Laboratory Medicine, 20159 Milan, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.31083/j.fbl2702074
?:doi
?:hasPublicationType
?:journal
  • Frontiers in bioscience (Landmark edition)
is ?:pmid of
?:pmid
?:pmid
  • 35227017
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Performance evaluation of four surrogate Virus Neutralization Tests (sVNTs) in comparison to the in vivo gold standard test.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all